New U.S. travel rules excludes foreigners vaccinated with Russia's Sputnik V
2021-10-13 06:13:45
Associated Press news report headlined - Russians flock to Serbia for Western-made Covid-19 Vaccines – described families from Rostov-on-Don located in southern Russia, wanted to visit the West, looked for a vaccine that would allow them to travel freely - a quest that brought them to Serbia.
New U.S. travel rules excludes foreigners vaccinated with Russia's Sputnik V
Local and foreign media have stepped up reports about rising Covid-19 infections in Russia. The reports indicated high deaths in the country. Some new trends noticeably appear. Interestingly, Tourism and Travel agencies have revealed that vaccine uptake has lagged in Russia and worse, due to mistrust, many Russians are lining up for what is now referred to as "vaccination tourism" in Serbia, Bulgaria, Germany and a few other foreign countries.
Associated Press news report headlined - Russians flock to Serbia for Western-made Covid-19 Vaccines – described families from Rostov-on-Don located in southern Russia, wanted to visit the West, looked for a vaccine that would allow them to travel freely - a quest that brought them to Serbia.
Serbia, which is not a member of the European Union, is a convenient choice for vaccine-seeking Russians because they can enter the allied Balkan nation without visas and because it offers a wide choice of Western-made shots. Organized tours for Russians have soared, and travel mostly to vaccination clinics in foreign countries such as Serbia.
These Russians aim at getting foreign vaccines including Pfizer, Moderna and Johnson & Johnson and AstraZeneca approved by the World Health Organization. China has also received certification for its vaccines from World Health Organization. Sputnik V is still awaiting approval from the European Medicines Agency (EMA) before all travel limitations be lifted for people vaccinated with the Russian formula.
Amid low vaccination rates and further squeezed between both technical and political controversies, Russia is now pushing for approval to boost confidence in its domestically developed vaccine, but has encountered administrative issues thus delaying the decision-making process.
World Health Organization is reviewing data about Russia's Sputnik V coronavirus vaccine before approving it for emergency use. "As with other candidate vaccines, World Health Organization continues to assess Sputnik V vaccines from different manufacturing sites and will publish decisions on their EUL (emergency use listing) status when all the data are available and the review is concluded," the World Health Organization said in a statement on October 5.
As soon as World Health Organization receives all data and inspects production sites, the UN group can schedule a meeting to validate a candidate vaccine for an emergency use listing. Without World Health Organization recognition, people that have taken the Sputnik V vaccine may be limited in their travel if other countries with entry restrictions don't recognize the shot.
Here are a few facts about Russian vaccines:
Russia's Sputnik V was the first officially registered coronavirus vaccine on August 11, 2020, far faster than the vaccines approved in the United States and Europe. Currently, Russia is using four vaccines for mass vaccination for Covid-19. These are Sputnik V and Sputnik Light developed by the Russian Health Ministry's Gamaleya Center.
EpiVacCorona developed by the Vector Center of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor), and CoviVac developed by the Chumakov Institute of the Russian Academy of Sciences. Clinical trials of the EpiVacCorona vaccine on teens aged from 15 to 17 might begin in the near future.
China has 1.3 billion population and marked or gave its two billionth vaccine in August, the United States has 380 million and vaccinated 60% of its population. In Europe, vaccination rate is highly at an appreciable level. That compared, Russia with an estimated 146 million people has Europe's highest death toll from the pandemic, more than 210,000 people as at September 30, according to various authentic sources including the National Coronavirus Task Force.
On October 11, Interfax News Agency reported that Russia had registered 29,409 new cases of Covid-19 and 957 deaths in the past 24 hours, quoting the coronavirus response headquarters. Some experts, however, argue that the actual number of infections could be even higher, - but Kremlin has, at first, shrugged off the steep level of infections and fatalities.
"The numbers are really very bad, and this is indeed a cause for concern. The main reason is the insufficient level of vaccination. The virus is getting more virulent... As a rule, those who have not been vaccinated are severely ill and unfortunately die," Kremlin Spokesman Dmitry Peskov told reporters on a conference call.
"As of October 8, a total of 47.8 million people in Russia have received, at least, one dose of a two-shot Covid-19 vaccine, while 42.4 million have completed their coronavirus vaccination course and 2.1 million revaccinated," Deputy Prime Minister Tatyana Golikova said, as part of her weekly report during a cabinet meeting.
She gave an assurance back in July that once the population have been immunized with at least the first component of a two-shot vaccine, herd immunity to Covid-19, or at least an 80% vaccination rate, should be reached by November 1.
Even though Russia boasted of creating the world's first coronavirus vaccines, vaccination is very low. Critics have principally blamed a botched vaccine rollout and mixed messages the authorities have been sending about the outbreak. In addition, coronavirus antibody tests are popular in Russia and some observers suggest this contributes to the low vaccination numbers.
Western health experts say the antibody tests are unreliable either for diagnosing Covid-19 or assessing immunity to it. The antibodies that these tests look for can only serve as evidence of a past infection. Scientists say it's still unclear what level of antibodies indicates that a person has protection from the virus and for how long.
Russian Direct Investment Fund (RDIF), World Health Organization and the European Medicines Agency (EMA) could not be reached for comments on these questions and series of emails were not answered.
Russian Direct Investment Fund (RDIF) is in charge of all aspects of the Russian vaccines including production, distribution and marketing. Russia has registered Sputnik V in many foreign countries. The World Health Organization is yet to register this vaccine. For its certification, it must necessarily pass through approved procedures, according reports.
There have also been several debates after the World Health Organization paused its review process of the Sputnik V vaccine over concerns about its manufacturing process, and few other technical reasons. While some talked about politicizing the vaccine registration, other have faced facts of the necessity and, of course the essence in observing recognized international rules for certifying medical products as such vaccines.
During the first week of October, Russian Health Minister Mikhail Murashko has reiterated or repeated assertively that a certain package of documents were still needed to continue the process for the approval of the Russian coronavirus vaccine Sputnik V by the World Health Organization. The final approval is expected towards the end of 2021.
Still some the problems with the registration as unfair competition in the global market. For instance, Russian Minister of Industry and Trade Denis Manturov said in an interview with the Rossiya-24 television channel on October 5: "I think it is an element of competition. Until Pfizer covers a certain part of the market, it is pure economics."
On the other side, Pyotr Ilyichev, Director for International Organizations Dept. at the Russian Foreign Affairs Ministry, told Interfax News Agency, for instance that World Health Organization has been playing politics around Russian vaccine especially when it is need in most parts of the world.
"The world is facing an acute shortage of vaccines for the novel coronavirus infection. In certain regions, for instance in African countries, less than 2% of the population has been vaccinated. The Russian vaccine is in demand, and the UN stands ready to buy it," he told Interfax.
"However, certification in the WHO is a complex, multi-step process, which was developed in the past in line with Western countries' standards. It requires time and serious efforts from our producers. We hope that this process will be successfully finalized in the near future," Ilyichev said.
Chairman of the State Duma's Foreign Affairs Committee Leonid Slutsky has described as discriminatory a decision reported by foreign media that the United States, under its new consular rules, would deny entry for foreigners immunized with the Russian Covid-19 vaccine Sputnik V.
"Thus, the U.S. will blatantly embark on a path of 'vaccine discrimination.' There are absolutely no grounds for such decisions. The efficacy and safety of the Sputnik V vaccine have been confirmed not only by specialists, but also by its use in practice," Slutsky said on Telegram. He cited an article in The Washington Post saying that from November the United States may begin denying entry to foreigners vaccinated with Sputnik V.
It means that if such additional border measures are adopted, foreigners seeking entry to the United States will have to be immunized with vaccines approved for use either by American authorities or the World Health Organization.
According to an article published in The Washington Post, for the first time since the pandemic began, the U.S. intends to loosen entry restrictions for foreigners vaccinated against Covid-19. The new rules, which enter into force in November, will not apply to Russians vaccinated with Sputnik V and citizens of other countries using this Russian vaccine.
The United States Food and Drug Administration has authorized three COVID-19 vaccines for emergency use during the pandemic: Moderna, Johnson & Johnson and Pfizer-BioNTech. The World Health Organization granted approval for those three as well as the Oxford-AstraZeneca/Covishield, Sinopharm and Sinovac vaccines.
Under the new rules, foreigners will enter United States only if they are immunized with vaccines approved for use by the United States Food and Drug Administration or the World Health Organization. Russia's Sputnik V is yet to be approved by the World Health Organization and is not recognized by the United States and European Union.
Local and foreign media have stepped up reports about rising Covid-19 infections in Russia. The reports indicated high deaths in the country. Some new trends noticeably appear. Interestingly, Tourism and Travel agencies have revealed that vaccine uptake has lagged in Russia and worse, due to mistrust, many Russians are lining up for what is now referred to as "vaccination tourism" in Serbia, Bulgaria, Germany and a few other foreign countries.
Associated Press news report headlined - Russians flock to Serbia for Western-made Covid-19 Vaccines – described families from Rostov-on-Don located in southern Russia, wanted to visit the West, looked for a vaccine that would allow them to travel freely - a quest that brought them to Serbia.
Serbia, which is not a member of the European Union, is a convenient choice for vaccine-seeking Russians because they can enter the allied Balkan nation without visas and because it offers a wide choice of Western-made shots. Organized tours for Russians have soared, and travel mostly to vaccination clinics in foreign countries such as Serbia.
These Russians aim at getting foreign vaccines including Pfizer, Moderna and Johnson & Johnson and AstraZeneca approved by the World Health Organization. China has also received certification for its vaccines from World Health Organization. Sputnik V is still awaiting approval from the European Medicines Agency (EMA) before all travel limitations be lifted for people vaccinated with the Russian formula.
Amid low vaccination rates and further squeezed between both technical and political controversies, Russia is now pushing for approval to boost confidence in its domestically developed vaccine, but has encountered administrative issues thus delaying the decision-making process.
World Health Organization is reviewing data about Russia's Sputnik V coronavirus vaccine before approving it for emergency use. "As with other candidate vaccines, World Health Organization continues to assess Sputnik V vaccines from different manufacturing sites and will publish decisions on their EUL (emergency use listing) status when all the data are available and the review is concluded," the World Health Organization said in a statement on October 5.
As soon as World Health Organization receives all data and inspects production sites, the UN group can schedule a meeting to validate a candidate vaccine for an emergency use listing. Without World Health Organization recognition, people that have taken the Sputnik V vaccine may be limited in their travel if other countries with entry restrictions don't recognize the shot.
Here are a few facts about Russian vaccines:
Russia's Sputnik V was the first officially registered coronavirus vaccine on August 11, 2020, far faster than the vaccines approved in the United States and Europe. Currently, Russia is using four vaccines for mass vaccination for Covid-19. These are Sputnik V and Sputnik Light developed by the Russian Health Ministry's Gamaleya Center.
EpiVacCorona developed by the Vector Center of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor), and CoviVac developed by the Chumakov Institute of the Russian Academy of Sciences. Clinical trials of the EpiVacCorona vaccine on teens aged from 15 to 17 might begin in the near future.
China has 1.3 billion population and marked or gave its two billionth vaccine in August, the United States has 380 million and vaccinated 60% of its population. In Europe, vaccination rate is highly at an appreciable level. That compared, Russia with an estimated 146 million people has Europe's highest death toll from the pandemic, more than 210,000 people as at September 30, according to various authentic sources including the National Coronavirus Task Force.
On October 11, Interfax News Agency reported that Russia had registered 29,409 new cases of Covid-19 and 957 deaths in the past 24 hours, quoting the coronavirus response headquarters. Some experts, however, argue that the actual number of infections could be even higher, - but Kremlin has, at first, shrugged off the steep level of infections and fatalities.
"The numbers are really very bad, and this is indeed a cause for concern. The main reason is the insufficient level of vaccination. The virus is getting more virulent... As a rule, those who have not been vaccinated are severely ill and unfortunately die," Kremlin Spokesman Dmitry Peskov told reporters on a conference call.
"As of October 8, a total of 47.8 million people in Russia have received, at least, one dose of a two-shot Covid-19 vaccine, while 42.4 million have completed their coronavirus vaccination course and 2.1 million revaccinated," Deputy Prime Minister Tatyana Golikova said, as part of her weekly report during a cabinet meeting.
She gave an assurance back in July that once the population have been immunized with at least the first component of a two-shot vaccine, herd immunity to Covid-19, or at least an 80% vaccination rate, should be reached by November 1.
Even though Russia boasted of creating the world's first coronavirus vaccines, vaccination is very low. Critics have principally blamed a botched vaccine rollout and mixed messages the authorities have been sending about the outbreak. In addition, coronavirus antibody tests are popular in Russia and some observers suggest this contributes to the low vaccination numbers.
Western health experts say the antibody tests are unreliable either for diagnosing Covid-19 or assessing immunity to it. The antibodies that these tests look for can only serve as evidence of a past infection. Scientists say it's still unclear what level of antibodies indicates that a person has protection from the virus and for how long.
Russian Direct Investment Fund (RDIF), World Health Organization and the European Medicines Agency (EMA) could not be reached for comments on these questions and series of emails were not answered.
Russian Direct Investment Fund (RDIF) is in charge of all aspects of the Russian vaccines including production, distribution and marketing. Russia has registered Sputnik V in many foreign countries. The World Health Organization is yet to register this vaccine. For its certification, it must necessarily pass through approved procedures, according reports.
There have also been several debates after the World Health Organization paused its review process of the Sputnik V vaccine over concerns about its manufacturing process, and few other technical reasons. While some talked about politicizing the vaccine registration, other have faced facts of the necessity and, of course the essence in observing recognized international rules for certifying medical products as such vaccines.
During the first week of October, Russian Health Minister Mikhail Murashko has reiterated or repeated assertively that a certain package of documents were still needed to continue the process for the approval of the Russian coronavirus vaccine Sputnik V by the World Health Organization. The final approval is expected towards the end of 2021.
Still some the problems with the registration as unfair competition in the global market. For instance, Russian Minister of Industry and Trade Denis Manturov said in an interview with the Rossiya-24 television channel on October 5: "I think it is an element of competition. Until Pfizer covers a certain part of the market, it is pure economics."
On the other side, Pyotr Ilyichev, Director for International Organizations Dept. at the Russian Foreign Affairs Ministry, told Interfax News Agency, for instance that World Health Organization has been playing politics around Russian vaccine especially when it is need in most parts of the world.
"The world is facing an acute shortage of vaccines for the novel coronavirus infection. In certain regions, for instance in African countries, less than 2% of the population has been vaccinated. The Russian vaccine is in demand, and the UN stands ready to buy it," he told Interfax.
"However, certification in the WHO is a complex, multi-step process, which was developed in the past in line with Western countries' standards. It requires time and serious efforts from our producers. We hope that this process will be successfully finalized in the near future," Ilyichev said.
Chairman of the State Duma's Foreign Affairs Committee Leonid Slutsky has described as discriminatory a decision reported by foreign media that the United States, under its new consular rules, would deny entry for foreigners immunized with the Russian Covid-19 vaccine Sputnik V.
"Thus, the U.S. will blatantly embark on a path of 'vaccine discrimination.' There are absolutely no grounds for such decisions. The efficacy and safety of the Sputnik V vaccine have been confirmed not only by specialists, but also by its use in practice," Slutsky said on Telegram. He cited an article in The Washington Post saying that from November the United States may begin denying entry to foreigners vaccinated with Sputnik V.
It means that if such additional border measures are adopted, foreigners seeking entry to the United States will have to be immunized with vaccines approved for use either by American authorities or the World Health Organization.
According to an article published in The Washington Post, for the first time since the pandemic began, the U.S. intends to loosen entry restrictions for foreigners vaccinated against Covid-19. The new rules, which enter into force in November, will not apply to Russians vaccinated with Sputnik V and citizens of other countries using this Russian vaccine.
The United States Food and Drug Administration has authorized three COVID-19 vaccines for emergency use during the pandemic: Moderna, Johnson & Johnson and Pfizer-BioNTech. The World Health Organization granted approval for those three as well as the Oxford-AstraZeneca/Covishield, Sinopharm and Sinovac vaccines.
Under the new rules, foreigners will enter United States only if they are immunized with vaccines approved for use by the United States Food and Drug Administration or the World Health Organization. Russia's Sputnik V is yet to be approved by the World Health Organization and is not recognized by the United States and European Union.
News
powered by Surfing Waves
Support ASCARF
ASCARF is a tax-exempt Public Benefit Organisation (PBO) that supports Public Benefit Activities (PBA). ASCARF appreciates your donations to develop the mission into global online Research Center. All accumulated funds to be forwarded to our Public Benefit Activities and outstanding authors. Thank you in advance!